MeSH term
Frequency | Condition_Probility | Adult | 2 | 0.0 |
Comparative Study | 5 | 0.0 |
Cyclic GMP/pharmacology | 3 | 17.0 |
Humans | 36 | 0.0 |
Milrinone/pharmacology | 2 | 66.0 |
Platelet Aggregation/*drug effects | 2 | 1.0 |
Research Support, Non-U.S. Gov't | 22 | 0.0 |
Animals | 14 | 0.0 |
Cyclic AMP/physiology | 2 | 1.0 |
Female | 4 | 0.0 |
Meiosis/physiology | 2 | 18.0 |
Research Support, U.S. Gov't, P.H.S. | 14 | 0.0 |
3',5'-Cyclic-Nucleotide Phosphodiesterase/genetics/*metabolism | 3 | 30.0 |
Cells, Cultured | 5 | 0.0 |
Cyclic AMP/metabolism | 8 | 1.0 |
Cyclic GMP/metabolism | 3 | 3.0 |
Gene Expression | 4 | 0.0 |
Male | 6 | 0.0 |
Phosphodiesterase Inhibitors/*pharmacology | 4 | 8.0 |
Rats | 3 | 0.0 |
Vasoconstriction | 2 | 11.0 |
Cyclic GMP/*pharmacology | 2 | 28.0 |
Insects | 2 | 1.0 |
Kinetics | 7 | 0.0 |
Models, Molecular | 4 | 0.0 |
Protein Conformation | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Substrate Specificity | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Binding Sites | 3 | 0.0 |
Catalytic Domain | 2 | 0.0 |
Cyclic AMP/*metabolism | 2 | 0.0 |
Immunoblotting | 2 | 0.0 |
*Mutagenesis, Site-Directed | 2 | 2.0 |
Amino Acid Sequence | 9 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Blotting, Western | 4 | 0.0 |
Cloning, Molecular | 7 | 0.0 |
Mice | 5 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Molecular Sequence Data | 14 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 6 | 0.0 |
Transfection | 3 | 0.0 |
Phosphodiesterase Inhibitors/pharmacology | 7 | 6.0 |
Quinolones/pharmacology | 2 | 18.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Base Sequence | 8 | 0.0 |
DNA Primers | 2 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Catalysis | 2 | 0.0 |
Molecular Weight | 2 | 0.0 |
Myocardium/enzymology | 4 | 5.0 |
Sequence Alignment | 2 | 0.0 |
3',5'-Cyclic-Nucleotide Phosphodiesterase/chemistry/genetics/*metabolism | 2 | 66.0 |
Cell Line | 2 | 0.0 |
Sequence Deletion | 3 | 0.0 |
Blood Platelets/*enzymology | 4 | 5.0 |
Cattle | 2 | 0.0 |
Mutagenesis, Site-Directed | 4 | 0.0 |
1-Methyl-3-isobutylxanthine/pharmacology | 2 | 2.0 |
Clone Cells | 2 | 0.0 |
3',5'-Cyclic-Nucleotide Phosphodiesterase/*genetics | 2 | 20.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Tritium | 2 | 0.0 |
3',5'-Cyclic-Nucleotide Phosphodiesterase/*metabolism | 2 | 18.0 |
Immunohistochemistry | 2 | 0.0 |
In Vitro | 3 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
